We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of ADVM yet.

ADVM Hedge Fund Activity: Q4 2025 in Review

0 of the 8,226 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q4 2025, worth a combined $0 — down 100% from $63.8M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of ADVM and 0 opened new positions — a net loss of 50 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BML Capital Management, exiting entirely with an estimated $13.9M sold.

  • 0 institutional investors held Adverum Biotechnologies (ADVM) as of Q4 2025, down from 50 in Q3 2025.
  • Funds reported $0 of Adverum Biotechnologies stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Adverum Biotechnologies positions in Q4 2025 and 50 closed out, a net change of -50 holders.
  • The largest Adverum Biotechnologies seller in Q4 2025 was BML Capital Management, an estimated $13.9M sold.

Based on aggregated 13F filings for Q4 2025.